Tungs' Taichung Metroharbour Hospital
Clinical trials sponsored by Tungs' Taichung Metroharbour Hospital, explained in plain language.
-
Gut health boost may ease toxin burden in dialysis patients
Disease control Not yet recruitingThis study tests whether a 12-week multispecies synbiotic supplement can lower harmful gut-derived toxins and inflammation in 30 adults on hemodialysis. The goal is to improve gut health and reduce complications like heart disease. Participants must be on dialysis for at least 3 …
Phase: NA • Sponsor: Tungs' Taichung Metroharbour Hospital • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Gut check: dialysis patients test 'Good Bacteria' to fight toxins
Knowledge-focused Not yet recruitingThis study looks at whether a daily supplement of 'good bacteria' (synbiotic) can improve gut health and reduce harmful toxins in the blood of people on dialysis. Researchers will measure changes in gut bacteria, toxin levels, and gut barrier function over 12 weeks in 30 adult di…
Phase: NA • Sponsor: Tungs' Taichung Metroharbour Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC